title: [A 72 week follow-up study of chronic hepatitis C patients treated with peginterferon alfa-2b and ribavirin].
authors.affiliation: Hospital of Infectious Diseases of Jinan, Jinan 250021, China. yushuli999@126.com
authors.forename: Shu-li
authors.initials: SL
authors.lastname: Yu
authors.forename: Zhao-hua
authors.initials: ZH
authors.lastname: Zhang
authors.forename: Hui
authors.initials: H
authors.lastname: Lv
authors.forename: Qin-gang
authors.initials: QG
authors.lastname: Zhang
authors.forename: Yao-zong
authors.initials: YZ
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b